CFDE Data Portal | Search RNY3

	Label	Description
	RNY3 associations Collection (Entity type)	Associations for RNY3_associations
	RNY3 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	RNY3 Gene (Entity type)	ENSG00000202354 - RNA, Ro60-associated Y3
	GSE205714 GSE229013 adenosine 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE203267 ALKBH5 knockdown Ramia 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE225901 dexamethasone 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE85880 GSE85881 tretinoin cardiac muscle cell 4 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE156761 dopamine neuron 0 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE174745 dopamine neuron 1 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE98856 adenosine 6 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS

RNY3 associations

Associations for RNY3_associations

RNY3 associations.tsv

A file from IDG as part of the Harmonizome project

RNY3

ENSG00000202354 - RNA, Ro60-associated Y3

GSE205714 GSE229013 adenosine 3 v 2 human up

A Gene Set from LINCS

GSE203267 ALKBH5 knockdown Ramia 0 v 1 human dn

A Gene Set from LINCS

GSE225901 dexamethasone 0 v 1 human up

A Gene Set from LINCS

GSE85880 GSE85881 tretinoin cardiac muscle cell 4 v 1 human dn

A Gene Set from LINCS

GSE156761 dopamine neuron 0 v 3 human dn

A Gene Set from LINCS

GSE174745 dopamine neuron 1 v 5 human dn

A Gene Set from LINCS

GSE98856 adenosine 6 v 0 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.